← Back to Glossary← Back to Glossary
E
Extreme Adverse Event Classification
Biopharmaceutical Glossary
Extreme adverse event classification establishes protocols for unprecedented, catastrophic reactions warranting immediate investigation and reporting. Spontaneous reporting captures unexpected severe events. Expedited regulatory notification communicates serious safety signals. Causality assessment determines relationship likelihood. Risk mitigation strategies address identified hazards.
Risk-benefit reassessment may warrant market withdrawal. Communication to healthcare providers highlights dangers. Patient notification enables informed decision-making. Regulatory actions range from labelling changes to removal. Post-incident monitoring prevents recurrence.
